Navigation Links
IADR and GSK Consumer Healthcare announce winners of 2010 Innovation in Oral Care Awards
Date:5/14/2010

Alexandria, Va., USA The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare today announced the 2010 winners of the annual IADR/GSK Innovation in Oral Care Awards. The three prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and the quality of life.

In its seventh year of award support, GSK Consumer Healthcare has contributed more than $1.6 million. Each of the three 2010 winners will receive a $75,000 unrestricted research grant, which is funded by GSK Consumer Healthcare and administered by IADR. The 2010 winners are:

Robert Patrick Allaker, B.Sc., Ph.D., University of London, Institute of Dentistry for "Multifunctional Nano-biomaterials for Implant-based Dental Reconstruction Products." Hydroxyapatite (HA) is chemical similar to mineral components of bone and hard tissues. Owing to its excellent biocompatibility, it is used in a wide range of applications as bone and dental implant material. However, it is well recognized that bacterial infection is a significant cause of implant failure. There is thus an urgent need for technologies that can effectively prevent such infection from occurring. Implant coatings with durable antimicrobial properties together with enhanced bone compatibility will lead to a reduction in the total number of revisions and an increase in the expected implant lifespan, considerably reducing the attributable economic burden and patient morbidity.

Daniel Grenier, Ph.D., Groupe de Recherche en Ecologie Buccale, Universit Laval, Qubec, Canada, for "Therapeutic Potential of Citrus Auraptene for Periodontal Disease." Given the high prevalence of gum diseases in the population, if this study demonstrates that auraptene possesses beneficial properties for oral health, it will support its common use as a preventive or therapeutic agent. Plant-derived natural compounds endowed with a capacity to exert anti-microbial activity toward oral pathogens and to modulate the host inflammatory response may be potential new therapeutic agents for periodontal infections. Auraptene is found in high amounts in citrus fruits and has been reported to possess a variety of valuable pharmacological properties such as anti-oxydant, anti-inflammatory, and anti-bacterial activities. For a preventive approach, auraptene may be added into mouthwash or incorporated into a chewing gum. For therapeutic purpose, auraptene may be incorporated into a gel or fiber for topical application into diseased periodontal sites.

Craig Miller, D.M.D, M.S., University of Kentucky College of Dentistry, USA, "POC Immunoassay Test Strip for the Diagnosis of Periodontal Disease." A portable point-of-care (POC) diagnostic immunoassay test strip in the hands of the general public, as well as diverse health care personnel, could lead to significant increases in screening for oral diseases and referrals to appropriate oral health care experts. This, in turn, should lead to a significant paradigm shift whereupon the public has the opportunity for more preventive engagement in identifying their personalized health risk using self-care, handheld devices for the evaluation of the presence or absence of periodontal diseases and thus enhance their proactive solicitation of the health care system.

"This is the seventh year that GSK has had the opportunity to partner with IADR and sponsor the Innovation in Oral Care Awards," said Dr. Stuart R. Smith, Vice President Global Dental Scientific and Professional Communications for GSK. "GSK is honored to be able to help these talented investigators further their innovative research, and I hope that this research leads to the development of new technology and products that prevent and treat oral and dental diseases."

This year, the IADR/GSK Innovation in Oral Care Awards received 34 applications from teams of researchers from around the globe. Each application was reviewed by a panel of experts under the chairmanship of Professor Lakshman Samaranayake, Dean and Tam Wah-Ching Professor of Dental Sciences at the University of Hong Kong, Prince Philip Dental Hospital.

The awards will be presented during the 88th General Session & Exhibition of the IADR, to be held July 14-17, 2010, in Barcelona, Spain.

"IADR applauds GSK for continuing to support oral health research and the Innovation in Oral Care Awards," said IADR President Professor David M. Williams. "There is a great need for effective prevention as well as more effective treatments for those suffering from oral diseases. IADR is grateful that GSK is enabling these teams of researchers to develop novel concepts that have the potential to improve oral health worldwide."


'/>"/>

Contact: Ingrid L. Thomas
ithomas@iadr.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. Landmark Textbook Aims to Improve Clinician, Consumer Understanding of Lesbian Health
2. Milwaukee Wave Scores with Consumer Driven Health Care in 2010
3. FDA Consumer Health Information - FDAs MedWatch Safety Alerts: January 2010
4. AidRight Hearing Aids Tells Consumers to Order Professional Care with That Hearing Aid
5. Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting
6. Statement from the Consumer Healthcare Products Association on Mississippi Bill that Limits Consumer Access to Cold and Allergy Medicines Containing Pseudoephedrine by Requiring a Prescription
7. 5150 Juice Launches Pocket-Sized Syringe Containing 166.6mg of Liquid Caffeine for Consumers to Add To Their Favorite Drink
8. Consumer Reports Health: Central-Line Infection Rates In Boston Hospitals Vary Dramatically; Some Hospitals Not Reporting
9. Consumer Reports Health: Central-Line Infection Rates in Atlanta Hospitals Vary; One Hospital Reports Rates Up to 6 Times National Average; Some Hospitals Not Reporting
10. Consumer Reports Health: Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist
11. Consumer Reports Health: Central-Line Infection Rates in Los Angeles Hospitals Vary Dramatically; Some Hospitals Not Reporting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: